HCFA releases IVUS payment policies
The Health Care Financing Administration has established reimbursementpolicies covering physicians for the use of intravascular ultrasound(IVUS) during therapeutic interventions, according to IVUS developerEndosonics of Rancho Cordova, CA. The policies
The Health Care Financing Administration has established reimbursementpolicies covering physicians for the use of intravascular ultrasound(IVUS) during therapeutic interventions, according to IVUS developerEndosonics of Rancho Cordova, CA. The policies became effectiveJan. 1.
While third-party payors are increasingly reimbursing for IVUS,the HCFA policies represent the first nationwide healthcare policydecision in the U.S. granting reimbursement to physicians forusing the procedure, the company said.
Under the new policies, physicians can select from six differentcodes for IVUS, such as IVUS for one vessel and then subsequentvessels. In addition, there are also codes for coronary or peripheralvessels.
Guidelines for computing physician reimbursement vary acrossthe nation based on local service cost factors. Current indicationsare that the average reimbursement levels for coronary usage willrange from $95 to $254 for the first vessel and from $74 to $180for each subsequent vessel, depending on the service location(in hospital or outpatient), according to Endosonics.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
